2024-03-28T17:11:57Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_5715
2024-03-23T02:23:58Z
serval:BIB_5715
Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy.
8558208
A1996TP68700037
Pecherstorfer
M.
author
Herrmann
Z.
author
Body
J.J.
author
Manegold
C.
author
Degardin
M.
author
Clemens
M.R.
author
Thürlimann
B.
author
Tubiana-Hulin
M.
author
Steinhauer
E.U.
author
van Eijkeren
M.
author
Huss
H.J.
author
Thiébaud
D.
author
article
1996
Journal of Clinical Oncology
0732-183X
0732-183X
journal
14
1
268-276
Adult
Aged
Aged, 80 and over
Bone Resorption
Calcium/blood
Diphosphonates/adverse effects
Diphosphonates/pharmacology
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Fever/chemically induced
Humans
Hypercalcemia/blood
Hypercalcemia/drug therapy
Male
Middle Aged
Nausea/chemically induced
Neoplasms/complications
Recurrence
Regression Analysis
Thrombocytopenia/chemically induced
Treatment Outcome
eng
60_published
Publication types: Clinical Trial ; Clinical Trial, Phase II ; Comparative Study ; Journal Article ; Multicenter Study ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
Publication Status: ppublish